USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 178 filers reported holding USANA HEALTH SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $342,559 | -59.8% | 5,434 | -59.9% | 0.00% | – |
| Q1 2023 | $853,176 | +117.6% | 13,564 | +94.2% | 0.00% | – |
| Q3 2022 | $392,000 | -19.8% | 6,985 | +3.5% | 0.00% | – |
| Q2 2022 | $489,000 | -77.6% | 6,752 | -68.7% | 0.00% | – |
| Q4 2021 | $2,186,000 | +61.2% | 21,600 | +46.9% | 0.00% | – |
| Q3 2021 | $1,356,000 | +222.9% | 14,700 | +258.5% | 0.00% | – |
| Q2 2021 | $420,000 | -77.4% | 4,100 | -78.5% | 0.00% | – |
| Q1 2021 | $1,861,000 | -13.9% | 19,067 | -32.0% | 0.00% | – |
| Q4 2020 | $2,162,000 | +222.7% | 28,052 | +208.3% | 0.00% | – |
| Q3 2020 | $670,000 | -41.2% | 9,100 | -41.3% | 0.00% | – |
| Q2 2020 | $1,139,000 | -85.7% | 15,505 | -88.8% | 0.00% | -100.0% |
| Q1 2020 | $7,978,000 | +393.1% | 138,139 | +570.6% | 0.00% | – |
| Q4 2019 | $1,618,000 | -27.8% | 20,600 | -37.1% | 0.00% | – |
| Q3 2019 | $2,241,000 | -66.5% | 32,776 | -61.0% | 0.00% | – |
| Q2 2019 | $6,684,000 | +569.7% | 84,126 | +606.9% | 0.00% | – |
| Q1 2019 | $998,000 | +57.2% | 11,900 | +120.4% | 0.00% | – |
| Q4 2018 | $635,000 | -44.5% | 5,400 | -43.2% | 0.00% | – |
| Q3 2018 | $1,145,000 | -15.8% | 9,500 | -19.5% | 0.00% | – |
| Q2 2018 | $1,360,000 | +4.2% | 11,800 | -22.4% | 0.00% | – |
| Q1 2018 | $1,305,000 | -66.4% | 15,200 | -71.0% | 0.00% | -100.0% |
| Q4 2017 | $3,888,000 | +12.3% | 52,500 | -12.5% | 0.00% | 0.0% |
| Q3 2017 | $3,462,000 | +92.1% | 60,000 | +113.5% | 0.00% | +100.0% |
| Q2 2017 | $1,802,000 | +85.6% | 28,100 | +77.1% | 0.00% | – |
| Q4 2016 | $971,000 | -78.8% | 15,864 | -53.5% | 0.00% | -100.0% |
| Q3 2015 | $4,570,000 | -18.6% | 34,100 | -17.0% | 0.00% | 0.0% |
| Q2 2015 | $5,617,000 | +23.0% | 41,100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $4,567,000 | -34.2% | 41,100 | -39.2% | 0.00% | -33.3% |
| Q4 2014 | $6,938,000 | +203.0% | 67,627 | +117.5% | 0.00% | +200.0% |
| Q3 2014 | $2,290,000 | +1028.1% | 31,089 | +1094.4% | 0.00% | – |
| Q2 2014 | $203,000 | -92.1% | 2,603 | -91.2% | 0.00% | -100.0% |
| Q3 2013 | $2,562,000 | -55.0% | 29,524 | -62.4% | 0.00% | -66.7% |
| Q2 2013 | $5,689,000 | – | 78,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |